Data / Form D filings / Can-Fite BioPharma Ltd.
Can-Fite BioPharma Ltd.: Form D filings
Can-Fite BioPharma Ltd., a pharmaceuticals company in Ramat Gan, Israel, filed 15 Form D notices with the SEC between 2014 and 2026. The latest, on September 10, 2026, reports $8.3 million sold of a $8.3 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 26 BEN GURION STREET, Ramat Gan, Israel, 52573
- Phone
- +972 (3) 924-1114
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Israel
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1536196
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 10, 2026 | New notice | $8,306,884 | $8,306,884 | 1 | Sep 2, 2026 | sec.gov | |
| Dec 30, 2021 | New notice | $10,000,000 | $10,000,000 | 1 | Dec 20, 2021 | sec.gov | |
| Aug 26, 2021 | New notice | $9,996,900 | $9,996,900 | 1 | Aug 11, 2021 | sec.gov | |
| Jul 17, 2020 | New notice | $3,411,000 | $3,411,000 | 3 | Jul 6, 2020 | sec.gov | |
| Jun 19, 2020 | New notice | $8,000,002 | $8,000,002 | 4 | Jun 10, 2020 | sec.gov | |
| Jan 24, 2020 | New notice | $2,400,000 | $2,400,000 | 4 | Jan 9, 2020 | sec.gov | |
| May 31, 2019 | New notice | $6,000,000 | $6,000,000 | 5 | May 20, 2019 | sec.gov | |
| Apr 11, 2019 | New notice | $3,200,000 | $3,200,000 | 2 | Apr 2, 2019 | sec.gov | |
| Jan 24, 2019 | New notice | $2,350,000 | $2,350,000 | 1 | Jan 18, 2019 | sec.gov | |
| Mar 22, 2018 | New notice | $5,000,004 | $5,000,004 | 3 | Mar 13, 2018 | sec.gov | |
| Jan 25, 2017 | New notice | $5,000,000 | $5,000,000 | 8 | Jan 24, 2017 | sec.gov | |
| Oct 28, 2015 | New notice | $4,825,002 | $4,825,002 | 3 | Oct 15, 2015 | sec.gov | |
| Oct 2, 2015 | New notice | $9,000,002 | $9,000,002 | 3 | Sep 21, 2015 | sec.gov | |
| Dec 17, 2014 | New notice | $8,000,000 | $8,000,000 | 4 | Dec 8, 2014 | sec.gov | |
| Mar 24, 2014 | New notice | $5,059,072 | $5,059,072 | 16 | Mar 10, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Motti Farbstein | Executive Officer | Chief Executive Officer, Chief Financial Officer and Chief Operating Officer |
| Pnina Fishman | Executive Officer | Executive Chairman of the Board and Chief Scientific Officer |
| Sari Fishman | Executive Officer | Vice President of Business Development |
| Guy Regev | Director | |
| Abraham Sartani | Director | |
| Yoseph Bornstein | Director | |
| Ilan Tamir | Director |
Every Form D from the week of Sep 7, 2026 · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Can-Fite BioPharma Ltd. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.